Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Floreo has developed an immersive virtual reality platform to teach social, communication, behavioral, emotional regulation, and life skills to neurodiverse individuals. The company’s technology has received FDA Breakthrough Device Designation for its autism therapy software. Early clinical research shows promise in improving outcomes such as eye contact and social engagement in ASD. The product is commercially available on a subscription basis and used by providers, schools, and families.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Floreo.